
Daily Derm Times: August 13, 2025
Key Takeaways
- Dermatologic studies address cybersecurity, compression therapy for cellulitis, and melanoma overdiagnosis, reflecting diverse research areas in dermatology.
- Personalized systemic therapies for atopic dermatitis focus on patient needs, treatment options, and adherence to improve outcomes.
Catch up on dermatology news, highlights, and insights from the past 24 hours.
To stay up-to-date with the latest dermatology news, sign up to receive our
Journal Digest: August 13, 2025
This review of the latest dermatologic studies includes findings on cybersecurity practices in dermatology, compression therapy for cellulitis, melanoma overdiagnosis, and more.
Practical Guidance for Utilizing Dermatology Times Event Systemic Therapies in Atopic Dermatitis
Explore personalized systemic therapies for atopic dermatitis, addressing patient needs, treatment options, and enhancing adherence for better outcomes.
Vitiligo's Deep Impact on Life Choices
Vitiligo significantly influences patients' quality of life, affecting major life decisions and increasing perceived stigma.
Pembrolizumab Becomes First Approved Perioperative Immunotherapy for Resectable HNSCC in Canada
Merck's pembrolizumab gains Health Canada approval for innovative perioperative treatment of advanced head and neck squamous cell carcinoma, enhancing patient outcomes.
The Most Popular Vitiligo Content on TikTok Lacks Medical Accuracy
TikTok's vitiligo content reveals a critical need for reliable clinical information from HCPs, highlighting the gap between engagement and accuracy in health education.
Q&A: Celebrating the First Annual GPP Awareness Day
Shannon C. Trotter, DO, FAOCD, FAAD, and patient Janene Tirado, highlight GPP Awareness Day and the urgent need for recognition and understanding of generalized pustular psoriasis.
3 Cases, 3 Triumphs: Rethinking AD Management
Explore innovative nonsteroidal treatments for atopic dermatitis, as experts discuss personalized care strategies to enhance patient quality of life.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















